Shaanxi Micot Pharmaceutical Technology Co., Ltd.

Quick facts

Phase 3 pipeline

• MT1013 · Immunology
  MT1013 is a small molecule that targets the PDE4 enzyme.

Phase 2 pipeline

• Long-term Dosing Cohort
• MT200605
• Multiple ascending doses of MT1013
• Single ascending doses of MT1013

Phase 1 pipeline

• MT1011

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Shaanxi Micot Pharmaceutical Technology Co., Ltd. portfolio CI brief
• Shaanxi Micot Pharmaceutical Technology Co., Ltd. pipeline updates RSS